1 Min Read
Oct 11 (Reuters) - Nanoviricides Inc :
* Nanoviricides has filed annual report, says company has sufficient cash to advance into clinical trials Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.